Global At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, Other Form Types), Age (Pediatric, Adult, Geriatric), Sample Type (Urine, Blood, Saliva, Others), Usage (Disposable, Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, Online Pharmacies) - Industry Trends and Forecast to 2031.
At-Home Testing Kits Market Analysis and Size
At-home testing kits are testing instruments that help a person perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at a very affordable rate. Self-tests are usually the advanced versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by the common person.
Data Bridge Market Research analyzes that the global at-home testing kits market which was USD 7.44 billion in 2023, is likely to reach USD 11.95 billion by 2031, and is expected to undergo a CAGR of 6.1% during the forecast period. “Portable devices" dominate the distribution channel segment of the market due to increasing awareness of proper treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, Other Form Types), Age (Pediatric, Adult, Geriatric), Sample Type (Urine, Blood, Saliva, Others), Usage (Disposable, Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, Online Pharmacies)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East & Africa
|
|
Market Players Covered
|
Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (Becton, Dickinson and Company) (U.S.), Drägerwerk AG & Co. KGaA (Germany) , LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (Rapikit) (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.S.), Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.), Biosynex (France), PRIMA Lab SA (Switzerland), MP BIOMEDICALS (U.S.), Sterilab Services (France), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia)
|
|
Market Opportunities
|
|
Market Definition
At-home testing kits, also known as home test kits or home diagnostic kits, are medical or health-related devices that allow individuals to perform specific tests or screenings for various conditions or diseases within the comfort of their own homes. These kits typically include necessary tools, instructions, and sometimes, prepaid packaging to send the collected samples back to a laboratory for analysis. At-home testing kits are designed to provide convenient and private ways for individuals to monitor their health, assess certain biomarkers, or detect specific health conditions without visiting a healthcare facility. These kits are commonly used for various purposes, such as pregnancy tests, blood glucose monitoring, DNA testing, sexually transmitted infection (STI) tests, and more.
Global At-Home Testing Kits Market Dynamics
Drivers
- Growing Adoption of Self-Testing Kits
Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behaviour has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor. This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.
- Testing Easy Availability of Self-Testing Kits at Pharmacies
At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits. This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.
Opportunities
- Telehealth Integration
The growing adoption of telehealth services presents an opportunity for at-home testing kits. Integrated telehealth platforms can streamline the process of obtaining test results, consultations, and further medical guidance.
- Technological Advancements
Advances in technology, especially in the fields of diagnostics and biosensors, have led to the development of more accurate and user-friendly at-home testing kits. Improved accuracy, simplicity, and speed contribute to the market's growth.
Restraints/Challenges
- Regulatory Challenges
Stringent regulatory requirements for the approval of at-home testing kits can pose a challenge for manufacturers. Navigating complex regulatory landscapes may slow down the introduction of new products to the market.
- Limited Test Offerings
Some complex diagnostic tests may not be feasible for at-home use, limiting the scope of testing kits. Certain medical conditions may still require laboratory-based tests for accurate results.
Global At-Home Testing Kits Market Scope
The at-home testing kits market is segmented into six notable segments based on test type, type, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Pregnancy Test
- HIV Test Kit
- Diabetes
- Infectious Diseases
- Glucose Tests
- Ovulation Predictor Test Kit
- Drug Abuse Test Kit
- Others
Type
- Cassette
- Strip
- Midstream
- Test Panel
- Dip Card
- Others
Age
- Pediatric
- Adult
- Geriatric
Sample Type
- Urine
- Blood
- Saliva
- Others
Usage
- Disposable
- Reusable
Distribution Channels
- Retail Pharmacies
- Drug Store
- Supermarket/Hypermarket
- Online Pharmacies
At-Home Testing Kits Market Regional Analysis/Insights
The at-home testing kits market is analyzed and market size insights and trends are provided based on test type, type, age, sample type, usage, and distribution channels as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E, Israel, Egypt, and rest of Middle East and Africa.
North America is expected to dominate and show the fastest growth in the market due to the region's high healthcare expenditure and the increasing awareness about the at-home testing kits market.
The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The at-home testing kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for at-home testing kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on at-home testing kits market. The data is available for historic period 2010-2020.
Competitive Landscape and At-Home Testing Kits Market Share Analysis
The at-home testing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to at-home testing kits market.
Some of the major players operating in the at-home testing kits market are:
- Abbott (U.S.)
- Siemens Healthcare GmbH (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (Becton, Dickinson and Company) (U.S.)
- Drägerwerk AG & Co. KGaA (Germany)
- LifeScan IP Holdings, LLC (U.S.)
- Ascensia Diabetes Care Holdings AG (Switzerland)
- Nectar Lifesciences Ltd. (Rapikit) (India)
- ACON Laboratories, Inc. (U.S.)
- Quidel Corporation (U.S.)
- ARKRAY USA, Inc. (U.S.)
- BTNX INC. (Canada)
- Atomo Diagnostics (Australia)
- Eurofins Scientific (Luxembourg)
- Piramal Enterprises Ltd. (India)
- Bionime Corporation (Taiwan)
- Nova Biomedical (U.S.)
- Cardinal Health (U.S.)
- OraSure Technologies (U.S.)
- Biolytical Laboratories Inc. (Canada)
- Everlywell, Inc. (U.S.)
- SA Scientific Ltd. (U.S.)
- Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.)
- Biosynex (France)
- PRIMA Lab SA (Switzerland)
- MP BIOMEDICALS (U.S.)
- Sterilab Services (France)
- Chembio Diagnostics, Inc. (U.S.)
- BioSure (U.K.)
- Selfdiagnostics OU (Estonia)
SKU-